Conclusions-Liver cirrhosis is a strong risk factor for pyogenic liver abscess associated with a poor prognosis.
Pyogenic liver abscesses are rare in industrialised countries, 1-3 and the incidence has been estimated at 1.1 per 100 000 person years in a Danish regional study. 4 Biliary disease, malignancy, bacterial infection in other intraabdominal organs, and bacteraemia are factors associated with the occurrence of liver abscess, but the disease is often cryptogenic. 2 4-8 However, an association between pyogenic liver abscess and liver cirrhosis has been suggested in case reports, and most often in patients with iron overload. [9] [10] [11] [12] In a few case series of patients with pyogenic liver abscesses, the prevalence of liver cirrhosis was 0.9-13%, 2 5 7 and the prevalence of chronic alcoholism was more than 10% in other studies. 4 13 To determine if liver cirrhosis is a risk factor for liver abscess, we estimated the incidence rate and 30 day case fatality rate of pyogenic liver abscess in a nationwide cohort of patients with liver cirrhosis referring to the entire Danish population.
Methods

STUDY POPULATION AND DATA SOURCES
Denmark has approximately 5.2 million inhabitants. Admission, stay, and treatment in Danish public hospitals are free. Records on hospital admissions have been computerised since 1977 in the Danish National Registry of Patients (NRP), and 99.9% of all discharges from somatic departments in the entire country are recorded here.
14 Each admission record includes the CPR number (see below), date of admission, date of discharge, and up to 20 discharge diagnoses.
Every Danish citizen has been recorded in the Central Person Registry (CPR) since 1968, using a personal identification number (CPR number) for each citizen. The CPR number is assigned at birth or immigration, and includes date of birth and an additional number carrying a code for sex.
The study was based on record linkage between two nationwide population based cohorts from the NRP. The first cohort included patients with liver cirrhosis and the second patients with pyogenic liver abscess. Diagnosis codes according to the Danish version of the International Classification for Diseases, 8th edition (ICD-8), were used for primary identification in the NRP. 15 Dates of death or emigration were obtained in the CPR.
IDENTIFICATION OF PATIENTS WITH LIVER
CIRRHOSIS
The inclusion criterion for this study cohort was at least one discharge with a diagnosis of liver cirrhosis: alcoholic cirrhosis (ICD-8=571.09), primary biliary cirrhosis (571.90), non-specified cirrhosis (571.92), chronic hepatitis (571.93), or other types of cirrhosis, alcoholism not indicated (571.99) from 1 January 1977 to 31 December 1993. The Danish version of ICD-8 makes it possible to modify the diagnoses using a sixth digit as a suYx to the diagnosis code, indicating for instance observation for, sequel, or earlier. As we had no access to the primary hospital records, yet we wanted to achieve the lowest possible rate of misclassification, we excluded all individuals with these modifications. Individuals less than 20 years of age were also excluded as liver cirrhosis is rare in this age group in Denmark and is usually associated with congenital malformations or inborn errors of metabolism.
The cohort was divided into two subcohorts: alcoholic liver cirrhosis and non-alcoholic liver cirrhosis. Cirrhotics with a diagnosis of alcoholism (ICD-8=303) at any time during the follow up period were always referred to the alcoholic subcohort, independent of the code for cirrhosis. The purpose of this was to reduce misclassification between the two subcohorts. 16 
17
IDENTIFICATION OF CASES OF LIVER ABSCESS
During the follow up period from 1 January 1977 to 31 December 1993, all cases of liver abscess were identified in the NRP, which was searched for the diagnosis codes for pyogenic liver abscess (572.01) and suppurative hepatitis (572.09). Cases with amoebic liver abscess were not included. Individuals with any modification of the diagnosis codes were also excluded from this cohort.
STATISTICAL ANALYSES
In the liver cirrhosis cohort, the follow up period started at the date of discharge from hospital with a diagnosis of cirrhosis and ended at the date of discharge with a diagnosis of liver abscess, date of death, date of emigration, or 31 December 1993, whichever came first.
The association between liver cirrhosis and liver abscess was notified only when the diagnosis of liver cirrhosis was made before or during the same admission as the diagnosis of pyogenic liver abscess. The purpose of this was to associate the diseases only if patients actually had liver cirrhosis when admitted with liver abscess. The follow up period for the background population was based on the number of inhabitants >20 years of age in Denmark for each year of the follow up period.
Incidence rate (IR) was calculated as the number of cases divided by the follow up time for each type of cirrhosis and sex. The incidence rate ratio (IRR) of liver abscess in the cirrhosis cohort was estimated by dividing the IR in the alcoholic cirrhosis subcohort by the IR in the non-alcoholic subcohort. The standardised incidence rate (SIR) of liver abscess was based on the age specific IR values in the cirrhosis cohort and in the background population, using 20 year age groups in sex specific strata.
Confidence intervals of 95% were estimated according to exact limits when expected numbers were less than 10 or otherwise according to the Poisson distribution. The expected numbers of cases of liver abscess in the cirrhosis cohort were estimated by multiplying the number of person years in cirrhotics by the IR found in the background population.
The relative risk (odds ratio) of 30 day case fatality in patients with liver abscess and liver cirrhosis adjusted for sex, age, and comorbidity was estimated using logistic regression models. 18 The cohort was subdivided according to age: less than 55 years (the reference category) and older than 55 years. The comorbidity index was estimated as described by Charlson and colleagues. 19 Liver diseases were not scored, and only discharge diagnoses registered at the same admission for pyogenic liver abscess were scored.
Results
The cirrhosis cohort comprised 22 764 individuals (table 1). In both subcohorts there was a shorter mean follow up period for men, and there was a considerably larger proportion of alcoholic men than women in the cohort. Sixty one percent of all patients with cirrhosis were alcoholics, and in these patients cirrhosis was diagnosed on average 8-10 years earlier than non-alcoholics, according to their age (table 1) .
The liver abscess cohort comprised 665 individuals, of whom 21 also had a diagnosis of liver cirrhosis.
The overall IR of pyogenic liver abscess in the liver cirrhosis cohort was 23.3 (14.6-35.6) per 100 000 person years (table 1). The overall IR of liver abscess in the background population (cirrhosis cohort not included) was 1.0 (0.9-1.1).
The increased risk of liver abscess in cirrhotics compared with the background population is shown in table 2. The overall age SIR was 15.4 (9.6-23.6). The SIRs of liver abscess in patients with alcoholic and non-alcoholic liver cirrhosis were 15.5 (8.2-26.5) and 15.7 (6.8-30.9) respectively, compared with the background population. However, the magnitude of the estimates changed according to age as the incidence rate ratios of liver abscess (IRR) in alcoholic cirrhotics and non-alcoholic cirrhotics diVered significantly in the two age groups: 3.3 (0.5-143.1) versus 0.4 (0.1-1.6) in cirrhotics younger and older than 55 years, respectively. Thus the SIRs in the two cirrhosis groups (table 2) should be related to the background population and not to each other. The first year after the diagnosis of liver cirrhosis was associated with the highest SIR for pyogenic liver abscess (36.4) but during the subsequent follow up period there was also a considerably increased risk of liver abscess in the cirrhosis cohort compared with the background population (table 2) . The overall 30 day case fatality rate in patients with liver abscess was 38.5% (13.9-68.4) for patients with alcoholic cirrhosis and 62.5% (24.5-91.5) for patients with nonalcoholic cirrhosis. A somewhat lower case fatality rate of 26.9% (23.5-30.5) was found among other patients with pyogenic liver abscess. After adjustment for age, sex, and comorbidity, both groups of cirrhotics had a more than fourfold higher risk of dying within 30 days than other patients with pyogenic liver abscess (table 3). There was however no significant diVerence between the two cirrhosis groups. Female sex and age greater than 55 years were also associated with an increased risk of dying in the liver abscess cohort. A high comorbidity index was a strong prognostic factor for death after diagnosis of pyogenic liver abscess (table 3) .
Discussion
In this nationwide population based study, we found a considerably increased risk of pyogenic liver abscess in patients with liver cirrhosis compared with the background population. We also found that liver abscess associated with cirrhosis increased the risk of dying within 30 days after admission more than fourfold compared with other patients with liver abscess.
Our registry based study design has strengths and limitations. The uniformly structured Danish health care system and the NRP enabled us to conduct a large population based study with a complete follow up. Our registry based estimate of the incidence rate of liver abscess in the background population is in close agreement with earlier findings in a Danish regional study in which several data collection methods were used. 4 Misclassification of discharge diagnosis codes, a well known methodological problem in registry based research, is probably less than 12%. 4 16 Any non-diVerential misclassification would tend to underestimate the association found in this study. Our data lack clinical details on patients. Increased hospitalisation and extensive diagnostic eVorts in cirrhotics could partly explain the association and is probably responsible in part for the high risk of pyogenic liver abscess found during the first year after diagnosis of liver cirrhosis (table 2) . However, given the magnitude of the association and the lack of compensatory eVect in the prognosis, the association between liver cirrhosis and pyogenic liver abscess found in the present study cannot be explained solely in terms of this bias.
Patients with liver cirrhosis have reduced transhepatic blood flow, increased portal pressure, and often ascites, which may compromise immune defences and increase intestinal permeability to bacteria. The macrophage function is impaired, 20 21 and KupVer cells are therefore probably less protective; the functions of neutrophilic leucocytes 22 23 and the complement system 24 are often impaired in liver cirrhosis. Furthermore, in the cirrhosis cohort there was a mean follow up time of only four years, undoubtedly due to a high mortality rate, which indicates that many cirrhotics were diagnosed late in the disease course where immunodysfunction is prominent. These relations may explain the increased risk of liver abscess in cirrhotics.
After stratification for age, the risk of pyogenic liver abscess in the alcoholic and non-alcoholic cirrhosis subcohorts varied over strata, which did not allow us to compare the risks for liver abscess in the two subcohorts. But we did find a substantially increased age adjusted risk of pyogenic liver abscess in both subcohorts compared with the background population. Therefore, the aetiology of liver cirrhosis is probably not a crucial factor for the increased risk of pyogenic liver abscess in cirrhosis. Cirrhosis itself seems to be an important risk factor for pyogenic liver abscess but nevertheless immunosuppresion caused by alcohol 25 is probably another important risk factor. 4 13 The short term prognosis in the liver abscess cohort was considerably worse in cirrhotics than in other patients, and we conclude that liver cirrhosis is a strong risk factor for liver abscess associated with a poor prognosis. This is probably due to impaired immune defences and structural changes in the cirrhotic liver. 2 Reference to the background population, cirrhosis cohort excluded. 3 Reference to the sex specific strata in the background population, cirrhosis patients excluded. 
